Retour
Fourchette du Jour
373,27 €
383,14 €
Fourchette 52 Semaines
373,26 €
623,61 €
Volume
254 563
Moyenne 50J / 200J
435,41 €
/
451,32 €
Clôture Précédente
377,99 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,9 | 0,4 |
| P/B | 5,4 | 2,9 |
| ROE % | 25,3 | 3,8 |
| Net Margin % | 10,5 | 3,9 |
| Rev Growth 5Y % | 4,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 4,28% annually over 5 years — modest growth
Earnings declined -12,17% over the past year
ROE of 25,28% indicates high profitability
Debt/Equity of 0,16 — conservative balance sheet
Generating 325,48M in free cash flow
Cash machine — converts 122,71% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
4,28%
Revenue (1Y)4,06%
Earnings (1Y)-12,17%
FCF Growth (3Y)9,10%
Qualité
Return on Equity
25,28%
ROIC22,37%
Net Margin10,48%
Op. Margin13,37%
Sécurité
Debt / Equity
0,16
Current Ratio1,05
Interest Coverage193,28
Valorisation
P/E Ratio
19,86
P/B Ratio5,38
EV/EBITDA15,81
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,06% | Revenue Growth (3Y) | 5,70% |
| Earnings Growth (1Y) | -12,17% | Earnings Growth (3Y) | -1,34% |
| Revenue Growth (5Y) | 4,28% | Earnings Growth (5Y) | -0,31% |
| Profitability | |||
| Revenue (TTM) | 2,53B | Net Income (TTM) | 265,24M |
| ROE | 25,28% | ROA | 16,17% |
| Gross Margin | 29,97% | Operating Margin | 13,37% |
| Net Margin | 10,48% | Free Cash Flow (TTM) | 325,48M |
| ROIC | 22,37% | FCF Growth (3Y) | 9,10% |
| Safety | |||
| Debt / Equity | 0,16 | Current Ratio | 1,05 |
| Interest Coverage | 193,28 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 19,86 | P/B Ratio | 5,38 |
| P/S Ratio | 2,08 | PEG Ratio | -2,78 |
| EV/EBITDA | 15,81 | Dividend Yield | 0,01% |
| Market Cap | 5,27B | Enterprise Value | 5,35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,53B | 2,43B | 2,26B | 2,13B | 2,14B |
| Net Income | 265,24M | 302,00M | 272,51M | 249,62M | 268,55M |
| EPS (Diluted) | 18,42 | 19,89 | 17,93 | 16,53 | 16,85 |
| Gross Profit | 758,34M | 854,35M | 798,82M | 765,09M | 769,80M |
| Operating Income | 338,25M | 366,49M | 340,57M | 343,50M | 343,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,64B | 1,67B | 1,67B | 1,44B | 1,34B |
| Total Liabilities | 660,61M | 549,58M | 560,22M | 643,30M | 719,45M |
| Shareholders' Equity | 979,41M | 1,12B | 1,11B | 798,72M | 623,27M |
| Total Debt | 154,76M | 140,84M | 155,11M | 247,01M | 323,54M |
| Cash & Equivalents | 74,52M | 178,35M | 263,96M | 74,13M | 32,90M |
| Current Assets | 302,62M | 394,75M | 500,84M | 272,61M | 230,29M |
| Current Liabilities | 287,13M | 285,70M | 312,05M | 297,21M | 302,40M |